ReviewCancers2022

Lenvatinib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Shijie Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.